|
🐜
|
Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast cancer: a single-group, open-label, phase 2 study.
19 auth.
Stephen E. Jones,
R. Collea,
D. Paul,
S. Sedlacek,
A. Favret,
I. Gore,
D. Lindquist,
F. Holmes,
M. Allison,
B. Brooks,
...
Raul M Portillo,
S. Vukelja,
Michael S. Steinberg,
C. Stokoe,
M. Crockett,
Yunfei Wang,
L. Asmar,
N. Robert,
J. O’Shaughnessy
|
7 |
2013 |
7
🐜
|
|
🐬
|
IFN-alpha induces homotypic adhesion and Leu-13 expression in human B lymphoid cells.
Sharon S. Evans,
R. Collea,
J. Leasure,
D. Lee
|
6 |
1993 |
6
🐬
|
|
🐜
|
Docetaxel and cyclooxygenase-2 inhibition with celecoxib for advanced non-small cell lung cancer progressing after platinum-based chemotherapy: a multicenter phase II trial.
8 auth.
F. Nugent,
W. Mertens,
S. Graziano,
N. Levitan,
R. Collea,
A. Gajra,
...
J. Marshall,
J. McCann
|
5 |
2005 |
5
🐜
|
|
🐬
|
Kaposi's sarcoma in patients with and without human immunodeficiency virus infection, in a tertiary referral centre in Kenya
O. Mwanda,
Pingfu Fu,
R. Collea,
C. Whalen,
S. Remick
|
5 |
2005 |
5
🐬
|
|
🐜
|
Feasibility assessment of a chemoresponse assay to predict pathologic response in neoadjuvant chemotherapy for breast cancer patients.
10 auth.
Zhibao Mi,
F. Holmes,
B. Hellerstedt,
J. Pippen,
R. Collea,
A. Backner,
...
Jason E Bush,
H. Gallion,
A. Wells,
J. O’Shaughnessy
|
5 |
2008 |
5
🐜
|
|
🐜
|
Incidence and Predictive Factors for Recovery of Ovarian Function in Amenorrheic Women in Their 40s Treated With Letrozole.
14 auth.
L. Krekow,
B. Hellerstedt,
R. Collea,
S. Papish,
Shrinivas M Diggikar,
R. Resta,
S. Vukelja,
F. Holmes,
Praveen K Reddy,
L. Asmar,
...
Yunfei Wang,
P. Fox,
S. Peck,
J. O’Shaughnessy
|
4 |
2016 |
4
🐜
|
|
🐜
|
O-111 Docetaxel and COX-2 inhibition with celecoxib in progressive non-small cell lung cancer (NSCLC): Promising progression-free survival in a phase II study
10 auth.
F. Nugent,
S. Graziano,
R. Collea,
N. Levitan,
A. Gajra,
J. Freeman,
...
C. O'Connell,
J. Marshall,
W. Mertens,
J. McCann
|
2 |
2003 |
2
🐜
|
|
🦁
|
Pegylated liposomal doxorubicin plus carboplatin in patients with metastatic breast cancer: a phase II study.
13 auth.
R. Collea,
F. Kruter,
J. Cantrell,
T. George,
S. Kruger,
A. Favret,
D. Lindquist,
A. Melnyk,
R. Pluenneke,
S. Shao,
...
M. Crockett,
L. Asmar,
J. O’Shaughnessy
|
2 |
2012 |
2
🦁
|
